Late blocking of peripheral TNF-α is ineffective after spinal cord injury in mice

Immunobiology

Volumn 218, Issue 2, 2013, Pages 281-284

  Vidal, Pía M ^a   Lemmens, Evi ^a   Geboes, Lies ^a   Vangansewinkel, Tim ^a   Nelissen, Sofie ^a   Hendrix, Sven ^a  

^a HASSELT UNIVERSITY   (Belgium)

Author keywords

Basso mouse scale; Enbrel; Etanercept; Rotarod; Tumor necrosis factor

Indexed keywords

ETANERCEPT; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASSO MOUSE SCALE; CHRONIC DISEASE; CONTINUOUS INFUSION; CONTROLLED STUDY; COORDINATION; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; IMMUNE RESPONSE; IN VIVO STUDY; INTRACELLULAR SIGNALING; LOCOMOTION; MACROPHAGE ACTIVATION; MOTOR PERFORMANCE; MOUSE; MUSCLE STRENGTH; NONHUMAN; OSMOTIC MINIPUMP; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; ROTAROD TEST; SCORING SYSTEM; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; THERAPY DELAY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; RECEPTORS, TUMOR NECROSIS FACTOR; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871924418     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.007     Document Type: Article

References (32)

1. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 1997, 9:1422.
2. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851.
3. Boato F., Hendrix S., Huelsenbeck S.C., Hofmann F., Grosse G., Djalali S., Klimaschewski L., Auer M., Just I., Ahnert-Hilger G., Holtje M. C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts. J. Cell Sci. 2010, 123:1652.
4. Basso D.M., Fisher L.C., Anderson A.J., Jakeman L.B., McTigue D.M., Popovich P.G. Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 2006, 23:635.
5. Beck K.D., Nguyen H.X., Galvan M.D., Salazar D.L., Woodruff T.M., Anderson A.J. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433.
6. Clarke D.J., Branton R.L. A role for tumor necrosis factor alpha in death of dopaminergic neurons following neural transplantation. Exp. Neurol. 2002, 176:154.
7. Chen K.B., Uchida K., Nakajima H., Yayama T., Hirai T., Watanabe S., Guerrero A.R., Kobayashi S., Ma W.Y., Liu S.Y., Baba H. Tumor necrosis factor-alpha antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine 2011, 36:1350. (Phila Pa 1976).
8. Chertoff M., Di Paolo N., Schoeneberg A., Depino A., Ferrari C., Wurst W., Pfizenmaier K., Eisel U., Pitossi F. Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor alpha in the nigrostriatal dopaminergic circuit of adult mice. Exp. Neurol. 2011, 227:237.
9. D'Souza S., Alinauskas K., McCrea E., Goodyer C., Antel J.P. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 1995, 15:7293.
10. Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., Bramanti P., Cuzzocrea S. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J. Pharmacol. Exp. Ther. 2006, 316:1006.
11. Genovese T., Mazzon E., Crisafulli C., Esposito E., Di Paola R., Muia C., Di Bella P., Meli R., Bramanti P., Cuzzocrea S. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 2007, 150:168.
12. Hendrix S., Nitsch R. The role of T helper cells in neuroprotection and regeneration. J. Neuroimmunol. 2007, 184:100.
13. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system I: expression and recognition. Trends Neurosci. 1995, 18:83.
14. Koopmans G.C., Deumens R., Buss A., Geoghegan L., Myint A.M., Honig W.H., Kern N., Joosten E.A., Noth J., Brook G.A. Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury. Exp. Neurol. 2009.
15. Kim G.M., Xu J., Song S.K., Yan P., Ku G., Xu X.M., Hsu C.Y. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J. Neurosci. 2001, 21:6617.
16. Lee Y.B., Yune T.Y., Baik S.Y., Shin Y.H., Du S., Rhim H., Lee E.B., Kim Y.C., Shin M.L., Markelonis G.J., Oh T.H. Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury. Exp. Neurol. 2000, 166:190.
17. Moreno B., Jukes J.P., Vergara-Irigaray N., Errea O., Villoslada P., Perry V.H., Newman T.A. Systemic inflammation induces axon injury during brain inflammation. Ann. Neurol. 2011, 70:932.
18. Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H., Barde Y.A. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 2002, 22:854.
19. Oshima T., Lee S., Sato A., Oda S., Hirasawa H., Yamashita T. TNF-alpha contributes to axonal sprouting and functional recovery following traumatic brain injury. Brain Res. 2009, 1290:102.
20. Pineau I., Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 2007, 267.
21. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 1998, 152:74.
22. Sullivan P.G., Bruce-Keller A.J., Rabchevsky A.G., Christakos S., Clair D.K., Mattson M.P., Scheff S.W. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 1999, 19:6248.
23. Schmitt K.R., Boato F., Diestel A., Hechler D., Kruglov A., Berger F., Hendrix S. Hypothermia-induced neurite outgrowth is mediated by tumor necrosis factor-alpha. Brain Pathol. 2010, 20:771.
24. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005, 25:3219.
25. Sheng H., Wang H., Homi H.M., Spasojevic I., Batinic-Haberle I., Pearlstein R.D., Warner D.S. A no-laminectomy spinal cord compression injury model in mice. J. Neurotrauma 2004, 21:595.
26. Takahashi J.L., Giuliani F., Power C., Imai Y., Yong V.W. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann. Neurol. 2003, 53:588.
27. Trivedi A., Olivas A.D., Noble-Haeusslein L.J. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin. Neurosci. Res. 2006, 6:283.
28. Teeling J.L., Cunningham C., Newman T.A., Perry V.H. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1. Brain Behav. Immun. 2010, 24:409.
29. Tracey K.J., Lowry S.F. The role of cytokine mediators in septic shock. Adv. Surg. 1990, 23:21.
30. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45.
31. Zhao P., Leonoudakis D., Abood M.E., Beattie E.C. Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity. Neuropharmacology 2010, 58:551.
32. Zhou Q.H., Sumbria R., Hui E.K., Lu J.Z., Boado R.J., Pardridge W.M. Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor. J. Pharmacol. Exp. Ther. 2011, 339:618.